Seth Painter, Director, National Accounts, Populus Media
Kristen Winters, CX Lead, Americas Hub, Commercial Model Innovation, Bayer

The patient experience can be augmented via technology in many different ways. This panel will explore some of the technology solutions that are having a positive impact on patient experiences, and also examine some of the underlying tenets that power them.

• What is patient experience as it pertains to technology?
• What are some of the basic understandings that need to be in place before applying technology to PX?
• What are some of the technologies that are making an impact?
• Where in the PX continuum could technology be better leveraged?
• What will we see in 2022 with regards to PX Tech?

Dan Landis, Associate Director, Channel Strategy & Access Programs, Aytu BioPharma
Lauren Murphy, Associate Director, Consumer Marketing, Biohaven Pharma
Kevin Hsieh, Service Lead, Web and Mobile, Genentech

Moderated by: Seth Painter, Director, National Accounts, Populus Media

Although businesses and their brands are unique and dynamic, there is a unified patient voice. Let this voice drive your digital engagement strategy. Learn how AI that listens and understands the patient can provide a smart start in addressing the Engagement Capacity Gap with real-time patient support.

Megan Brown, Director, Solutions and Consulting, Verint

This discussion will center around how pharma marketers are utilizing emerging technologies - like automation, voice & chat, AI/ML, VR/AR, connected devices - to deliver improved customer experiences and also drive revenue.

• What is the “state of the nation” for emerging technologies in commercial pharma?
• Examples of how voice, virtual assistants, chatbots, and NLP have improved CX or related performance.
• How does AI contribute to the performance/success of these functionalities?
• What’s missing? What’s next?

Dany De Grave, Founder, Unconventional Innovation, Sr. Director, Digital Transformation, Sanofi
Corinne Yaouanq-Lyngberg, Director- Omnichannel Strategic Enablement, Novo Nordisk
Beerju Patel, Non-Personal Promotion Lead, Media Strategy, AstraZeneca

Moderated by: Amy Turnquist, Principal, North Highland

The healthcare burden continues to increase and the complexity continues to grow. There is a high volume of inefficiencies in the market, which is becoming increasingly fragmented due to the infusion of venture capital dollars over the last five plus years ...and the 1,000s of start-up companies focused on addressing some particular aspect of healthcare.

What does this mean? And how can the marketer gain a better understanding of what a platform means to their business and their customer experience.

Jim Lefevere, International Business Leader, Digital Partnering Solutions, Roche

As part of the pill plus movement, most Pharma companies are creating digital support programs to provide more value to the broader patient and caregivers with their daily chronic health management needs (tracking, health literacy, timely intervention recommendations/motivations).

• How do you serve your patients beyond the pill?
• Strategies to give your app a better chance for success
• If apps aren’t the answer for you, what digital products/solutions are?
• Keys to positioning a digital product for internal buy-in/funding
• Change management to grow a culture that is ready to embrace a digital mindset

Steve Peretz, Director, Health Experience & Product Strategy, Appnovation
Mary Lassiter, Digital Platform Operations Lead, Bayer
Jim Lefevere, International Business Leader, Digital Partnering Solutions, Roche

Moderated by: Seth Painter, Director, National Accounts, Populus Media

In the CX continuum, the HCP is often overshadowed by the Patient. Focus needs to be placed on both, however, as the HCPs experience can make or break a brand. This discussion will highlight the importance of HCP Experience, some of the fundamental building blocks and the technologies that are optimizing the experience for prescribers.

• The latest in HCP engagement technology: What's working? What's not?
• What technologies do we wish we had?
• Examples of how technology is impacting the HCP experience
• How do you know a functionality is working towards improving HCPX?
• HCPX in 2022...and beyond: what’s on the roadmap?

Courtney Cramer, Associate Director, Keytruda Marketing, Merck
Robin Kamen, Global Lead, Omnichannel & CX, Galderma
Stephanie Garrison, Lead, Digital Marketing US, Idorsia Pharmaceuticals

Moderated by: Kristen Winters, CX Lead, Americas Hub, Commercial Model Innovation, Bayer

• Can CX be quantified using data?
• How is technology allowing brands to optimize CX by leveraging data?
• What can we learn from data about customer behavior patterns?
• Examples of pharma creating data products that drive CX automation

Vijay Iyengar, Sr. Director, Sales & Marketing, Eisai
Jeremy Pincus, Sr. Director, Global Digital Marketing Tech & Platforms, GSK
Anton Yarovoy, Director, Precision Medicine, Novartis

Moderated by: Seth Painter, Director, National Accounts, Populus Media

• What is your over-arching philosophy that powers digital transformation and, thus, your data strategy?
• What were the specific challenges as it pertained to data + CX…?
• How did those challenges impact CX?
• What approach do you take to your data? How do you tackle your data?
• On what three things are you focused on when organizing your data?

Michael Kirzhner, Associate Director, Brand Technology, Omnichannel Solutions, AbbVie